Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,218 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $719.49 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $460.84 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $149.64 | 8 | $0 (2024) |
| GENZYME CORPORATION | $138.59 | 6 | $0 (2024) |
| Shire North American Group Inc | $138.47 | 9 | $0 (2019) |
| ALK-Abello, Inc | $113.41 | 1 | $0 (2022) |
| Optinose US, Inc. | $91.45 | 6 | $0 (2024) |
| Genentech USA, Inc. | $74.12 | 3 | $0 (2022) |
| BioCryst US Sales Co., LLC | $63.41 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $45.46 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $397.84 | 19 | AstraZeneca Pharmaceuticals LP ($169.57) |
| 2023 | $228.85 | 11 | GlaxoSmithKline, LLC. ($72.87) |
| 2022 | $539.56 | 22 | AstraZeneca Pharmaceuticals LP ($196.11) |
| 2021 | $171.33 | 11 | GlaxoSmithKline, LLC. ($44.01) |
| 2020 | $47.81 | 3 | AstraZeneca Pharmaceuticals LP ($21.80) |
| 2019 | $196.56 | 12 | AstraZeneca Pharmaceuticals LP ($70.25) |
| 2018 | $370.62 | 22 | GlaxoSmithKline, LLC. ($121.54) |
| 2017 | $265.60 | 17 | GlaxoSmithKline, LLC. ($76.95) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $32.60 | General |
| 12/04/2024 | Aytu BioPharma, Inc. | Karbinal (Drug) | Food and Beverage | Cash or cash equivalent | $18.93 | General |
| Category: Pediatric Allergy | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 09/25/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Respiratory | ||||||
| 06/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Respiratory | ||||||
| 01/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Respiratory | ||||||
| 10/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology and Neurology | ||||||
| 08/23/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: RESPIRATORY | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 437 | 3,270 | $137,237 | $60,026 |
| 2022 | 11 | 333 | 3,388 | $116,081 | $56,726 |
| 2021 | 9 | 259 | 1,961 | $76,902 | $41,362 |
| 2020 | 11 | 250 | 1,307 | $103,350 | $29,749 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 140 | $25,760 | $15,079 | 58.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 75 | 134 | $22,512 | $6,776 | 30.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 18 | 478 | $10,994 | $6,233 | 56.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 41 | $10,127 | $6,048 | 59.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 65 | 106 | $17,278 | $5,694 | 33.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 24 | 1,464 | $17,568 | $5,613 | 31.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 72 | 132 | $9,108 | $4,470 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $8,711 | $3,787 | 43.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 18 | 341 | $9,889 | $3,462 | 35.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 20 | 371 | $5,194 | $2,859 | 55.0% |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | Office | 2023 | 11 | 16 | $48.00 | $3.29 | 6.9% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2023 | 11 | 16 | $48.00 | $1.76 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 152 | $27,968 | $16,867 | 60.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 63 | $15,561 | $9,391 | 60.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 27 | 1,776 | $21,312 | $7,142 | 33.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 14 | 427 | $9,821 | $5,981 | 60.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 25 | 469 | $6,566 | $3,960 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $8,149 | $3,587 | 44.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 13 | 310 | $8,990 | $3,084 | 34.3% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 53 | 82 | $5,658 | $2,822 | 49.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 25 | 29 | $4,727 | $1,599 | 33.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 26 | 30 | $5,040 | $1,530 | 30.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 17 | 21 | $2,289 | $762.25 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 131 | $24,104 | $15,157 | 62.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 32 | $7,904 | $5,202 | 65.8% |
About Dr. Arnold Kirshenbaum, M.D
Dr. Arnold Kirshenbaum, M.D is a Specialist healthcare provider based in Glen Burnie, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831145903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arnold Kirshenbaum, M.D has received a total of $2,218 in payments from pharmaceutical and medical device companies, with $397.84 received in 2024. These payments were reported across 117 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,218).
As a Medicare-enrolled provider, Kirshenbaum has provided services to 1,279 Medicare beneficiaries, totaling 9,926 services with total Medicare billing of $187,863. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Glen Burnie, MD
- Active Since 05/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1831145903
Products in Payments
- CUVITRU (Biological) $228.96
- FASENRA (Biological) $203.22
- TRELEGY ELLIPTA (Drug) $189.18
- TEZSPIRE (Biological) $150.64
- BREO (Drug) $139.68
- SYMBICORT (Drug) $132.25
- FASENRA (Drug) $120.13
- PRE-PEN (Drug) $113.41
- Xhance (Drug) $91.45
- DUPIXENT (Biological) $91.02
- NUCALA (Biological) $82.38
- AIRSUPRA (Drug) $76.00
- Xolair (Biological) $74.12
- AREXVY (Drug) $49.60
- Dymista (Drug) $45.46
- ORLADEYO (Drug) $42.63
- Xembify (Biological) $36.48
- TAKHZYRO (Biological) $35.30
- XOLAIR (Biological) $27.79
- CINRYZE (Drug) $23.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Glen Burnie
Dr. Harjit Bajaj, M.d, M.D
Specialist — Payments: $24,771
Dr. Zvezdomir Zamfirov, M.d, M.D
Specialist — Payments: $22,718
Dr. Marjorie Gwynn, Md, MD
Specialist — Payments: $8,462
Dr. Harvey Brilliant, Md, MD
Specialist — Payments: $6,378
Mr. James Murphy, M.d, M.D
Specialist — Payments: $3,517
Robin Ulanow, Md, MD
Specialist — Payments: $1,870